ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension

ClinicalTrials.gov ID: NCT00846365

Public ClinicalTrials.gov record NCT00846365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 7:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-Blind, Randomized, Efficacy and Safety Study Comparing the TAK-491 Plus Chlorthalidone Fixed-Dose Combination vs Benicar HCT® (Olmesartan Medoxomil-Hydrochlorothiazide) in Subjects With Moderate to Severe Essential Hypertension

Study identification

NCT ID
NCT00846365
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
1,085 participants

Conditions and interventions

Interventions

  • Azilsartan medoxomil and chlorthalidone Drug
  • Olmesartan medoxomil-hydrochlorothiazide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2009
Primary completion
May 31, 2010
Completion
May 31, 2010
Last update posted
Mar 12, 2012

2009 – 2010

United States locations

U.S. sites
70
U.S. states
28
U.S. cities
70
Facility City State ZIP Site status
Not listed Birmingham Alabama
Not listed Haleyville Alabama
Not listed Hueytown Alabama
Not listed Jasper Alabama
Not listed Tallassee Alabama
Not listed Green Valley Arizona
Not listed Phoenix Arizona
Not listed Long Beach California
Not listed National City California
Not listed Roseville California
Not listed San Francisco California
Not listed San Jose California
Not listed Newark Delaware
Not listed Clearwater Florida
Not listed Jacksonville Florida
Not listed Jupiter Florida
Not listed Miami Florida
Not listed Ocala Florida
Not listed Pembroke Pines Florida
Not listed Plant City Florida
Not listed Tallahassee Florida
Not listed Arlington Heights Illinois
Not listed Chicago Illinois
Not listed Gurnee Illinois
Not listed Avon Indiana
Not listed Wichita Kansas
Not listed Louisville Kentucky
Not listed Auburn Maine
Not listed Baltimore Maryland
Not listed Brockton Massachusetts
Not listed Haverhill Massachusetts
Not listed North Dartmouth Massachusetts
Not listed Bingham Farms Michigan
Not listed Stevensville Michigan
Not listed Olive Branch Mississippi
Not listed Kansas City Missouri
Not listed New York New York
Not listed Burlington North Carolina
Not listed Charlotte North Carolina
Not listed Hickory North Carolina
Not listed Shelby North Carolina
Not listed Akron Ohio
Not listed Cleveland Ohio
Not listed Columbus Ohio
Not listed Marion Ohio
Not listed Middleburg Heights Ohio
Not listed Willoughby Hills Ohio
Not listed Norman Oklahoma
Not listed Bensalem Pennsylvania
Not listed Erie Pennsylvania
Not listed Reading Pennsylvania
Not listed Cranston Rhode Island
Not listed Cumberland Rhode Island
Not listed North Charleston South Carolina
Not listed Jackson Tennessee
Not listed Kingsport Tennessee
Not listed Milan Tennessee
Not listed Austin Texas
Not listed Corpus Christi Texas
Not listed Dallas Texas
Not listed Houston Texas
Not listed San Antonio Texas
Not listed Salt Lake City Utah
Not listed Arlington Virginia
Not listed Burke Virginia
Not listed Charlottesville Virginia
Not listed Manassas Virginia
Not listed Lakewood Washington
Not listed Port Orchard Washington
Not listed Menomonee Falls Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00846365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2012 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00846365 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →